Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Roboz

Showing results (91-100 of 276) with videos related to

Pageof 28
Sort By:
Leukemia & Lymphoma|October 12, 2020
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapySangmin Lee, Pinkal Desai, Bianca Edirisinghe, et al.
European Journal of Biochemistry|April 1, 1994
Purification and characterization of three isolectins of soybean agglutinin. Evidence for C-terminal truncation by electrospray ionization mass spectrometryD K Mandal, E Nieves, L Bhattacharyya, et al.
Blood|August 15, 2000
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesisG J Roboz, S Dias, G Lam, et al.
Anticancer Research|August 11, 2001
High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivoJ D Jiang, H Zhang, J N Li, et al.
Annals of the New York Academy of Sciences|May 31, 1979
Immunologic dysfunction among PBB-exposed Michigan dairy farmersJ G Bekesi, H A Anderson, J P Roboz, et al.
Anti-Cancer Drug Design|June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant cloneM Weigand, G Hartung, J Roboz, et al.
Leukemia & Lymphoma|July 19, 2017
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabineJohn N Allan, Gail J Roboz, Gulce Askin, et al.
Drug and Chemical Toxicology|January 1, 1979
Impaired immune function and identification of polybrominated biphenyls (PBB) in blood compartments of exposed Michigan dairy farmers and chemical workersJ G Bekesi, J Roboz, H A Anderson, et al.
Leukemia Research|February 14, 2012
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?Gail J Roboz, Usama Wissa, Ellen K Ritchie, et al.
Cancer|May 14, 2020
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor typesHermann Einsele, Hossein Borghaei, Robert Z Orlowski, et al.
Pageof 28

Showing results (91-100 of 276) with videos related to

Sort By:
Pageof 28
Leukemia & Lymphoma|October 12, 2020
Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapySangmin Lee, Pinkal Desai, Bianca Edirisinghe, et al.
European Journal of Biochemistry|April 1, 1994
Purification and characterization of three isolectins of soybean agglutinin. Evidence for C-terminal truncation by electrospray ionization mass spectrometryD K Mandal, E Nieves, L Bhattacharyya, et al.
Blood|August 15, 2000
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesisG J Roboz, S Dias, G Lam, et al.
Anticancer Research|August 11, 2001
High anticancer efficacy of L-proline-m-bis (2-chloroethyl) amino-L-phenylalanyl-L-norvaline ethyl ester hydrochloride (MF13) in vivoJ D Jiang, H Zhang, J N Li, et al.
Annals of the New York Academy of Sciences|May 31, 1979
Immunologic dysfunction among PBB-exposed Michigan dairy farmersJ G Bekesi, H A Anderson, J P Roboz, et al.
Anti-Cancer Drug Design|June 7, 2002
Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant cloneM Weigand, G Hartung, J Roboz, et al.
Leukemia & Lymphoma|July 19, 2017
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabineJohn N Allan, Gail J Roboz, Gulce Askin, et al.
Drug and Chemical Toxicology|January 1, 1979
Impaired immune function and identification of polybrominated biphenyls (PBB) in blood compartments of exposed Michigan dairy farmers and chemical workersJ G Bekesi, J Roboz, H A Anderson, et al.
Leukemia Research|February 14, 2012
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?Gail J Roboz, Usama Wissa, Ellen K Ritchie, et al.
Cancer|May 14, 2020
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor typesHermann Einsele, Hossein Borghaei, Robert Z Orlowski, et al.
Pageof 28